CVS Health (CVS) Tops Q2 EPS by 22c, Sales Beat; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $79.96 --0%
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Cost of revenues: 37.12B
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.40, $0.22 better than the analyst estimate of $2.18. Revenue for the quarter came in at $80.6 billion versus the consensus estimate of $76.4 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.40-$8.60, versus prior of $8.20-$8.40 and the consensus of $8.36.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
- VisionChina (VISN) Tops Q3 EPS by 1c
- Holley Inc. (HLLY) Misses Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
